Aspire BioPharma, Inc.

CIK: 1995528PRIncorporated: 2021-09-27

Current Offering

$150,000
Target Amount
$5,000,000
Maximum Amount
2024-01-31
Deadline

Security Details

Type: Preferred Stock
Price per share: $0.80
Shares offered: 187,500+

Offering Costs

Cash commission: 7%
a) seven percent (7.0%) of ($0.00 - $2,000,000); b) five percent (5.0%) of ($2,000,000.01 - $4,000,000.00); and c) three percent (3.0%) of ($4,000,000.01 - $5,000,000)
Equity compensation: 2%
The Intermediary will also receive compensation in the form of securities equal to two percent (2%) of the total number of the securities sold in the Offering.

Financial Reports

Offering via Republic

Offering History

As of 2023-10-31
Raising $150,000 -$5,000,000 via 187,500+ shares of preferred Stock at $0.80 per share
Deadline: 2024-01-31
Filing date2023-10-31
Current employees0
Act received most recent fiscal year$0.00
Act received prior fiscal year$0.00
Cash equi most recent fiscal year$38.00
Cash equi prior fiscal year$185,496
Cost goods sold most recent fiscal year$0.00
Cost goods sold prior fiscal year$0.00
Long term debt most recent fiscal year$3,852,552
Long term debt prior fiscal year$0.00
Net income most recent fiscal year-$597,117.00
Net income prior fiscal year-$464,173.00
Revenue most recent fiscal year$0.00
Revenue prior fiscal year$0.00
Short term debt most recent fiscal year$193,881
Short term debt prior fiscal year$117,169
Tax paid most recent fiscal year$626.00
Tax paid prior fiscal year$626.00
Total asset most recent fiscal year$4,917,644
Total asset prior fiscal year$185,496

Company Information

Corporation
PR
2021-09-27

Latest Metrics

Employees0
Total Assets$4,917,644
Cash on Hand$38.00
Revenues$0.00
Net Income-$597,117.00

Crowdfunding Portals

This company is raising funds through this portal